Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2016 1
2018 2
2019 1
2020 1
2021 7
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years.
Patruno C, Fabbrocini G, Lauletta G, Boccaletti V, Colonna C, Cavalli R, Neri I, Ortoncelli M, Schena D, Stingeni L, Hansel K, Piccolo V, Di Brizzi V, Potenza C, Tolino E, Bianchi L, Manti S, De Pasquale R, Di Lernia V, Caminiti L, Galli E, Coppo P, Chiricozzi A, De Simone C, Guerriero C, Amoruso FG, Provenzano E, Leonardi S, Licari A, Marseglia GL, Palermo A, Di Pillo S, Russo D, Moschese V, Patella V, Peduto T, Ferreli C, Zangari P, Veronese F, Berti SF, Gruber M, Pezzolo E, Termine S, Satta R, Dragoni F, Esposito M, Fargnoli MC, Chiodini P, Vallone Y, di Vico F, Picone V, Napolitano M. Patruno C, et al. Among authors: provenzano e. J Dermatolog Treat. 2023 Dec;34(1):2246602. doi: 10.1080/09546634.2023.2246602. J Dermatolog Treat. 2023. PMID: 37580895 Free article.
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy.
Dastoli S, Passante M, Loconsole F, Mortato E, Balato A, Piccolo V, Guarneri C, Macca L, Provenzano E, Valenti G, D'Amico D, Micali G, Musumeci ML, Palazzo G, Foti C, Romita P, Fabbrocini G, Megna M, Sammarra I, Bennardo L, Patruno C. Dastoli S, et al. Among authors: provenzano e. J Dermatolog Treat. 2023 Dec;34(1):2200868. doi: 10.1080/09546634.2023.2200868. J Dermatolog Treat. 2023. PMID: 37026590 Free article.
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis.
Gori N, Chiricozzi A, Marsili F, Ferrucci SM, Amerio P, Battarra V, Campitiello S, Castelli A, Congedo M, Corazza M, Cristaudo A, Fabbrocini G, Girolomoni G, Malara G, Micali G, Palazzo G, Parodi A, Patrizi A, Pellacani G, Pigatto P, Provenzano E, Quaglino P, Romanelli M, Rossi M, Savoia P, Peris K. Gori N, et al. Among authors: provenzano e. J Clin Med. 2022 Sep 2;11(17):5204. doi: 10.3390/jcm11175204. J Clin Med. 2022. PMID: 36079131 Free PMC article.
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study.
Napolitano M, Fabbrocini G, Neri I, Stingeni L, Boccaletti V, Piccolo V, Amoruso GF, Malara G, De Pasquale R, Di Brizzi EV, Diluvio L, Bianchi L, Chiricozzi A, Di Guida A, Del Duca E, Moschese V, Di Lernia V, Dragoni F, Gruber M, Hansel K, Licari A, Manti S, Leonardi S, Mastorino L, Ortoncelli M, Provenzano E, Palermo A, Patella V, Peduto T, Pezzolo E, Piras V, Potestio L, Battista T, Satta R, Termine S, Palma P, Zangari P, Patruno C. Napolitano M, et al. Among authors: provenzano e. Paediatr Drugs. 2022 Nov;24(6):671-678. doi: 10.1007/s40272-022-00531-0. Epub 2022 Aug 27. Paediatr Drugs. 2022. PMID: 36028611 Free PMC article.
Erythema Migrans-like COVID Vaccine Arm: A Literature Review.
Fasano G, Bennardo L, Ruffolo S, Passante M, Ambrosio AG, Napolitano M, Provenzano E, Nisticò SP, Patruno C. Fasano G, et al. Among authors: provenzano e. J Clin Med. 2022 Feb 1;11(3):797. doi: 10.3390/jcm11030797. J Clin Med. 2022. PMID: 35160249 Free PMC article. Review.
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study.
Colombo D, Bianchi L, Fabbrocini G, Corrao S, Offidani A, Stingeni L, Costanzo A, Pellacani G, Peris K, Bardazzi F, Argenziano G, Ruffolo S, Dapavo P, Carrera C, Fargnoli MC, Parodi A, Romanelli M, Malagoli P, Talamonti M, Megna M, Raspanti M, Paolinelli M, Hansel K, Narcisi A, Conti A, De Simone C, Chessa MA, De Rosa A, Provenzano E, Ortoncelli M, Moltrasio C, Fidanza R, Burlando M, Tonini A, Gaiani FM, Simoni L, Ori A, Fiocchi M, Zagni E. Colombo D, et al. Among authors: provenzano e. Dermatol Ther. 2022 Jan;35(1):e15166. doi: 10.1111/dth.15166. Epub 2021 Nov 23. Dermatol Ther. 2022. PMID: 34676662
21 results